Global Drugs for Non-small Cell Lung Cancer Market Research Report 2016-2026

Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Drugs for Non-small Cell Lung Cancer Picture
1.1.2 Specifications
Table Product Specifications of Drugs for Non-small Cell Lung Cancer
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Drugs for Non-small Cell Lung Cancer
Table Global Drugs for Non-small Cell Lung Cancer Market by Type, 2016-2026 (USD Million)
1.2.1.1 Radiofrequency Ablation (RFA)
Table Radiofrequency Ablation (RFA) Overview
1.2.1.2 Radiation Therapy
Table Radiation Therapy Overview
1.2.1.3 Chemotherapy
Table Chemotherapy Overview
1.2.1.4 Targeted Therapies
Table Targeted Therapies Overview
1.2.1.5 Immunotherapy
Table Immunotherapy Overview
1.2.2 by Application
Table Application Segment of Drugs for Non-small Cell Lung Cancer
Table Global Drugs for Non-small Cell Lung Cancer Market by Application, 2016-2026 (USD Million)
1.2.2.1 Hospital
Table Hospital Overview
1.2.2.2 Clinic
Table Clinic Overview
1.2.2.3 Others
Table Others Overview
1.2.3 by Regions
Table Global Drugs for Non-small Cell Lung Cancer Market by Region, 2016-2026 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Drugs for Non-small Cell Lung Cancer
2.2 Upstream
Table Cost of Drugs for Non-small Cell Lung Cancer
Figure Manufacturing Process of Drugs for Non-small Cell Lung Cancer
2.3 Market
2.3.1 SWOT
Figure SWOT of Drugs for Non-small Cell Lung Cancer
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Drugs for Non-small Cell Lung Cancer
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Drugs for Non-small Cell Lung Cancer
3.4 Market Entry
Table Market Entry of Drugs for Non-small Cell Lung Cancer
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Radiofrequency Ablation (RFA) Market, 2016-2020
Figure Radiofrequency Ablation (RFA) Market Size and Growth, 2016-2020 (USD Million)
Figure Radiofrequency Ablation (RFA) Market Size and Growth, 2016-2020 (in Volume)
Table Radiofrequency Ablation (RFA) CAGR by Revenue and Volume, 2016-2020
4.1.2 Radiation Therapy Market, 2016-2020
Figure Radiation Therapy Market Size and Growth, 2016-2020 (USD Million)
Figure Radiation Therapy Market Size and Growth, 2016-2020 (in Volume)
Table Radiation Therapy CAGR by Revenue and Volume, 2016-2020
4.1.3 Chemotherapy Market, 2016-2020
Figure Chemotherapy Market Size and Growth, 2016-2020 (USD Million)
Figure Chemotherapy Market Size and Growth, 2016-2020 (in Volume)
Table Chemotherapy CAGR by Revenue and Volume, 2016-2020
4.1.4 Targeted Therapies Market, 2016-2020
Figure Targeted Therapies Market Size and Growth, 2016-2020 (USD Million)
Figure Targeted Therapies Market Size and Growth, 2016-2020 (in Volume)
Table Targeted Therapies CAGR by Revenue and Volume, 2016-2020
4.1.5 Immunotherapy Market, 2016-2020
Figure Immunotherapy Market Size and Growth, 2016-2020 (USD Million)
Figure Immunotherapy Market Size and Growth, 2016-2020 (in Volume)
Table Immunotherapy CAGR by Revenue and Volume, 2016-2020
4.2 Market Forecast
4.2.1 Radiofrequency Ablation (RFA) Market Forecast, 2021-2026
Figure Radiofrequency Ablation (RFA) Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Radiofrequency Ablation (RFA) Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Radiofrequency Ablation (RFA) CAGR by Revenue and Volume, 2016-2026
4.2.2 Radiation Therapy Market Forecast, 2021-2026
Figure Radiation Therapy Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Radiation Therapy Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Radiation Therapy CAGR by Revenue and Volume, 2016-2026
4.2.3 Chemotherapy Market Forecast, 2021-2026
Figure Chemotherapy Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Chemotherapy Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Chemotherapy CAGR by Revenue and Volume, 2016-2026
4.2.4 Targeted Therapies Market Forecast, 2021-2026
Figure Targeted Therapies Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Targeted Therapies Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Targeted Therapies CAGR by Revenue and Volume, 2016-2026
4.2.5 Immunotherapy Market Forecast, 2021-2026
Figure Immunotherapy Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Immunotherapy Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Immunotherapy CAGR by Revenue and Volume, 2016-2026
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Hospital Market, 2016-2020
Figure Hospital Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Hospital CAGR by Revenue and Volume, 2016-2020
5.1.2 Clinic Market, 2016-2020
Figure Clinic Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Clinic CAGR by Revenue and Volume, 2016-2020
5.1.3 Others Market, 2016-2020
Figure Others Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Others CAGR by Revenue and Volume, 2016-2020
5.2 Market Forecast
5.2.1 Hospital Market Forecast, 2021-2026
Figure Hospital Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Hospital Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Hospital CAGR by Revenue and Volume, 2021-2026
5.2.2 Clinic Market Forecast, 2021-2026
Figure Clinic Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Clinic Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Clinic CAGR by Revenue and Volume, 2021-2026
5.2.3 Others Market Forecast, 2021-2026
Figure Others Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Others Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Others CAGR by Revenue and Volume, 2021-2026
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2016-2020
Figure Asia-Pacific Market Size and Growth, 2016-2020 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2016-2020 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2016-2020
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2016-2020
Figure North America Market Size and Growth, 2016-2020 (USD Million)
Figure North America Market Size and Growth, 2016-2020 (in Volume)
Table North America CAGR by Revenue and Volume, 2016-2020
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2016-2020
Figure Europe Market Size and Growth, 2016-2020 (USD Million)
Figure Europe Market Size and Growth, 2016-2020 (in Volume)
Table Europe CAGR by Revenue and Volume, 2016-2020
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2016-2020
Figure South America Market Size and Growth, 2016-2020 (USD Million)
Figure South America Market Size and Growth, 2016-2020 (in Volume)
Table South America CAGR by Revenue and Volume, 2016-2020
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2016-2020
Figure Middle East & Africa Market Size and Growth, 2016-2020 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2016-2020 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2016-2020
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2021-2026
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2021-2026
6.2.2 North America Market Forecast, 2021-2026
Figure North America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure North America Market Estimates and Forecasts, 2021-2026 (in Volume)
Table North America CAGR by Revenue and Volume, 2021-2026
6.2.3 Europe Market Forecast, 2021-2026
Figure Europe Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Europe Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Europe CAGR by Revenue and Volume, 2021-2026
6.2.4 South America Market Forecast, 2021-2026
Figure South America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure South America Market Estimates and Forecasts, 2021-2026 (in Volume)
Table South America CAGR by Revenue and Volume, 2021-2026
6.2.5 Middle East & Africa Market Forecast, 2021-2026
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2021-2026
7 Market Competitive
7.1 Global Market by Vendors
Table Global Drugs for Non-small Cell Lung Cancer Market by Vendors, 2016-2020 (in Volume)
Table Global Drugs for Non-small Cell Lung Cancer Market Share by Vendors, 2016-2020 (USD Million)
Table Global Drugs for Non-small Cell Lung Cancer Market Share by Vendors, 2016-2020 (in Volume)
7.2 Market Concentration
Figure Drugs for Non-small Cell Lung Cancer Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Bristol-Myers Squibb
Table Bristol-Myers Squibb Profile List
Table Microecological Modulator Operating Data of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 GlaxoSmithKline
Table GlaxoSmithKline Profile List
Table Microecological Modulator Operating Data of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Menarini
Table Menarini Profile List
Table Microecological Modulator Operating Data of Menarini (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Sanofi
Table Sanofi Profile List
Table Microecological Modulator Operating Data of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Ziopharm Oncology
Table Ziopharm Oncology Profile List
Table Microecological Modulator Operating Data of Ziopharm Oncology (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 Alchemia
Table Alchemia Profile List
Table Microecological Modulator Operating Data of Alchemia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Amgen
Table Amgen Profile List
Table Microecological Modulator Operating Data of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Apotex
Table Apotex Profile List
Table Microecological Modulator Operating Data of Apotex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 BioMarin Pharmaceutical
Table BioMarin Pharmaceutical Profile List
Table Microecological Modulator Operating Data of BioMarin Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 CellAct Pharma
Table CellAct Pharma Profile List
Table Microecological Modulator Operating Data of CellAct Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.11 Cerulean Pharma
Table Cerulean Pharma Profile List
Table Microecological Modulator Operating Data of Cerulean Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.12 Cipla
Table Cipla Profile List
Table Microecological Modulator Operating Data of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.13 Cornerstone Pharmaceuticals
Table Cornerstone Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Cornerstone Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.14 Curis
Table Curis Profile List
Table Microecological Modulator Operating Data of Curis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.15 CytRx
Table CytRx Profile List
Table Microecological Modulator Operating Data of CytRx (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.16 Eli Lilly
Table Eli Lilly Profile List
Table Microecological Modulator Operating Data of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.17 Exelixis
Table Exelixis Profile List
Table Microecological Modulator Operating Data of Exelixis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.18 Fresenius Kabi
Table Fresenius Kabi Profile List
Table Microecological Modulator Operating Data of Fresenius Kabi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.19 Genentech
Table Genentech Profile List
Table Microecological Modulator Operating Data of Genentech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.20 Hikma Pharmaceuticals
Table Hikma Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Hikma Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.21 Hospira
Table Hospira Profile List
Table Microecological Modulator Operating Data of Hospira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.22 Intas Pharmaceuticals
Table Intas Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Intas Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.23 Karyopharm Therapeutics
Table Karyopharm Therapeutics Profile List
Table Microecological Modulator Operating Data of Karyopharm Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.24 Kyowa Hakko Kirin
Table Kyowa Hakko Kirin Profile List
Table Microecological Modulator Operating Data of Kyowa Hakko Kirin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.25 Ligand Pharmaceuticals
Table Ligand Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Ligand Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion